Home

PAR-20-084 - NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 4

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Technological Innovations for Advancing Clinical SPECT Imaging NOT-EB-22-006 NIBIB Mar 21, 2022 May 8, 2024 R21, F30, K01, R13, K23, K25, R43/R44, K08, R01, K99/R00, R41/R42, F32, R03, F31
Notice of Special Interest (NOSI): Navigating Pediatric to Adult Health Care: Lost in Transition NOT-HD-21-027 NICHD , NIAAA , NCI , NIMH , NIAMS , OBSSR , NIBIB , NIDCR Jun 22, 2021 Jan 8, 2024 R01, R21, R43/R44, R41/R42

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Participation of the National Institute on Aging (NIA) in PAR-20-084 "NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)" NOT-AG-22-019 NIA Mar 11, 2022 n/a R21
Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) NOT-EB-20-007 NIBIB Apr 10, 2020 Aug 29, 2020 R01, R21, R03


Technical Issues: E-mail OER Webmaster   




  • National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892

  • NIH... Turning Discovery Into Health